2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Abliva AB: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug-drug Interaction Study of KL1333 in Healthy Subjects KL1333, Flurbiprofen, Dextromethorphan - Mitochondrial Disease | Phase 1 | Completed | Abliva AB | 14 | 2020-11-10 | 2021-10-20 |
| A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease KL1333, Placebo Oral Tablet - Mitochondrial Diseases, Mitochondrial Respiratory Chain Deficiencies | Phase 1 | Completed | Abliva AB | 72 | 2019-03-18 | 2021-10-20 |
Mitochondrial Diseases (2) · Kearns-Sayre Syndrome (1) · MELAS Syndrome (1) · Mitochondrial Myopathies (1) · Ophthalmoplegia, Chronic Progressive External (1)
Bupropion (1) · Caffeine (1) · Dextromethorphan (1) · Flurbiprofen (1) · Midazolam (1) · Omeprazole (1) · repaglinide (1)
United Kingdom (2)